In 2011, we began aggressively exploiting both our health IT and biotech patents. The MichaelBass Group, a leading investment banking and strategic advisory services firm focused on health IT, issued a special report on January 20, 2012, valuing our health information technology patents at between $300-800 million based on the expected global growth of personal health records (http://michaelbass.com/PDF/JAN20MMRF.pdf).
On the wireless front, we recently demonstrated our work-in-progress application for Android phones. Soon, consumers will have access to their MyMedicalRecords PHR with a touch on their smartphones, and we are well on the way to making that happen.
In China, our Joint Venture with Unis-Tongue Technology is leading to the current installation of MMRPro systems in three hospitals in Henan Province, which has a population of some 100 million people.
We have also begun marketing to the multi-billion dollar veterinary business, working with Pets Best and "Dancing Paws" to launch our personal health records for the entire family including pets. Dancing Paws is owned in part by The RHL Group www.rhlgroup.com.
That said, a particular question that seems to be raised quarterly is the subject of a reverse split. I have said repeatedly that it has never come up in a Board of Directors meeting and it is not on the table at this time. Should it be considered, I believe it would be in connection with a significant business transaction or to uplist the Company to the Nasdaq or other national exchange.
ROTFL-- A high school dropout knows more than the rest of the Biotech industry. "" In fact, we were told by former Favrille management the Favrille biotech assets were "worthless."
News 
Market Data 
Discover 
